-
1دورية أكاديمية
المؤلفون: Tuba N. Gide, Elizabeth C. Paver, Zarwa Yaseen, Nigel Maher, Nurudeen Adegoke, Alexander M. Menzies, Ines Pires da Silva, James S. Wilmott, Georgina V. Long, Richard A. Scolyer
المصدر: OncoImmunology, Vol 12, Iss 1 (2023)
مصطلحات موضوعية: LAG-3, biomarker, immune checkpoint inhibitors, immunotherapy, melanoma, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: https://doaj.org/toc/2162-402XTest; https://doaj.org/article/de51474a80d24f65bee9d63be6c7447fTest
الإتاحة: https://doi.org/10.1080/2162402X.2023.2261248Test
https://doaj.org/article/de51474a80d24f65bee9d63be6c7447fTest -
2دورية أكاديمية
المؤلفون: Markus Zettl, Melanie Wurm, Otmar Schaaf, Sven Mostböck, Iñigo Tirapu, Ilse Apfler, Ivo C. Lorenz, Lee Frego, Cynthia Kenny, Michael Thibodeau, Elisa Oquendo Cifuentes, Markus Reschke, Jürgen Moll, Norbert Kraut, Anne Vogt, Jonathon D. Sedgwick, Irene C. Waizenegger
المصدر: OncoImmunology, Vol 11, Iss 1 (2022)
مصطلحات موضوعية: PD-1, LAG-3, ezabenlimab, BI 754091, BI 754111, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: https://doaj.org/toc/2162-402XTest; https://doaj.org/article/84794c7453c64c359a1ba6066ae5ae77Test
الإتاحة: https://doi.org/10.1080/2162402X.2022.2080328Test
https://doaj.org/article/84794c7453c64c359a1ba6066ae5ae77Test -
3دورية أكاديمية
المؤلفون: Jana Rakova, Iva Truxova, Peter Holicek, Cyril Salek, Michal Hensler, Lenka Kasikova, Josef Pasulka, Monika Holubova, Marek Kovar, Daniel Lysak, Justin P. Kline, Zdenek Racil, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova
المصدر: OncoImmunology, Vol 10, Iss 1 (2021)
مصطلحات موضوعية: co-inhibitory receptor, innate lymphoid cells, lag-3, tigit, vista, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: http://dx.doi.org/10.1080/2162402X.2021.1889822Test; https://doaj.org/toc/2162-402XTest; https://doaj.org/article/7aa2896ab527498bac5610f866169e29Test
الإتاحة: https://doi.org/10.1080/2162402X.2021.1889822Test
https://doaj.org/article/7aa2896ab527498bac5610f866169e29Test -
4دورية أكاديمية
المؤلفون: Haiping Jiang, Haiqing Ni, Pan Zhang, Xiaoli Guo, Min Wu, Haoran Shen, Jie Wang, Weiwei Wu, Zhihai Wu, Jiazheng Ding, Rong Tang, Shuaixiang Zhou, Bingliang Chen, Michael Yu, Hua Jing, Junjian Liu
المصدر: OncoImmunology, Vol 10, Iss 1 (2021)
مصطلحات موضوعية: pd-l1, lag-3, bispecific, cancer immunotherapy, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: http://dx.doi.org/10.1080/2162402X.2021.1943180Test; https://doaj.org/toc/2162-402XTest; https://doaj.org/article/9bf3fd5a07384c598ebd531f188b4d80Test
الإتاحة: https://doi.org/10.1080/2162402X.2021.1943180Test
https://doaj.org/article/9bf3fd5a07384c598ebd531f188b4d80Test -
5دورية أكاديمية
المصدر: OncoImmunology, Vol 10, Iss 1 (2021)
مصطلحات موضوعية: pd-1, lag-3, apc, tumor vaccine, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: http://dx.doi.org/10.1080/2162402X.2021.1912892Test; https://doaj.org/toc/2162-402XTest; https://doaj.org/article/78162b68b11746d59d937a79a9dce1cdTest
الإتاحة: https://doi.org/10.1080/2162402X.2021.1912892Test
https://doaj.org/article/78162b68b11746d59d937a79a9dce1cdTest -
6دورية أكاديمية
المؤلفون: Min Yang, Wenwen Du, Lixian Yi, Shaoxian Wu, Chunyan He, Wensi Zhai, Cuihua Yue, Runzi Sun, Ashley V. Menk, Greg M. Delgoffe, Jingting Jiang, Binfeng Lu
المصدر: OncoImmunology, Vol 9, Iss 1 (2020)
مصطلحات موضوعية: tim-3, lag-3, pd-1, exhaustion, tumor immunotherapy, combination therapy, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: http://dx.doi.org/10.1080/2162402X.2019.1708064Test; https://doaj.org/toc/2162-402XTest; https://doaj.org/article/f8aee54f31f8445996117a0211295b79Test
الإتاحة: https://doi.org/10.1080/2162402X.2019.1708064Test
https://doaj.org/article/f8aee54f31f8445996117a0211295b79Test -
7دورية أكاديمية
المصدر: OncoImmunology, Vol 9, Iss 1 (2020)
مصطلحات موضوعية: immune checkpoint blockade, lag-3, mutation burden, virus, endogenous retrovirus, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: http://dx.doi.org/10.1080/2162402X.2020.1756116Test; https://doaj.org/toc/2162-402XTest; https://doaj.org/article/d6dc8bdc526445cebab749c6c5ee6faaTest
الإتاحة: https://doi.org/10.1080/2162402X.2020.1756116Test
https://doaj.org/article/d6dc8bdc526445cebab749c6c5ee6faaTest -
8دورية أكاديمية
المؤلفون: Nicolas Gestermann, Damien Saugy, Christophe Martignier, Laure Tillé, Silvia A. Fuertes Marraco, Markus Zettl, Iñigo Tirapu, Daniel E. Speiser, Grégory Verdeil
المصدر: OncoImmunology, Vol 9, Iss 1 (2020)
مصطلحات موضوعية: checkpoint blockade, human melanoma, in vitro screening, pd-1, lag-3, autologous t cells, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: http://dx.doi.org/10.1080/2162402X.2020.1736792Test; https://doaj.org/toc/2162-402XTest; https://doaj.org/article/1305c4c5a45641c5a2eae2d6e2c5c1edTest
الإتاحة: https://doi.org/10.1080/2162402X.2020.1736792Test
https://doaj.org/article/1305c4c5a45641c5a2eae2d6e2c5c1edTest -
9دورية أكاديمية
المؤلفون: Samantha Burugu, Dongxia Gao, Samuel Leung, Stephen K. Chia, Torsten O. Nielsen
المصدر: OncoImmunology, Vol 7, Iss 11 (2018)
مصطلحات موضوعية: tim-3, breast cancer, immunohistochemistry, tumor-infiltrating lymphocytes, lag-3, pd-1, pd-l1, immune checkpoints, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: http://dx.doi.org/10.1080/2162402X.2018.1502128Test; https://doaj.org/toc/2162-402XTest; https://doaj.org/article/481d4dc6ccd6426893337d8f7ddf19daTest
الإتاحة: https://doi.org/10.1080/2162402X.2018.1502128Test
https://doaj.org/article/481d4dc6ccd6426893337d8f7ddf19daTest -
10دورية أكاديمية
المؤلفون: Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S. Hong, Lillian L. Siu, Miguel Martin, Michela Maur, Rina Hui, Ross A Soo, Joanne Chiu, Tian Zhang, Brigette Ma, Chrisann Kyi, Daniel SW Tan, Philippe A. Cassier, John Sarantopoulos, Andrew Weickhardt, Richard D. Carvajal, Jennifer Spratlin, Taito Esaki, Fréderic Rolland, Wallace Akerley, Barbara Deschler-Baier, Lawrence Rispoli, Tanay S. Samant, Niladri Roy Chowdhury, Daniel Gusenleitner, Eunice L. Kwak, Vasileios Askoxylakis, Filippo De Braud
المصدر: OncoImmunology, Vol 13, Iss 1 (2024)
مصطلحات موضوعية: Efficacy, ieramilimab, LAG-3 inhibitor, safety, spartalizumab, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: https://doaj.org/toc/2162-402XTest; https://doaj.org/article/fba32163599d40e7abcb0008f2589a1aTest
الإتاحة: https://doi.org/10.1080/2162402X.2023.2290787Test
https://doaj.org/article/fba32163599d40e7abcb0008f2589a1aTest